Literature DB >> 28973194

Shunt-Dependent Hydrocephalus After Aneurysmal Subarachnoid Hemorrhage: Predictors and Long-Term Functional Outcomes.

Gabriella M Paisan1, Dale Ding2, Robert M Starke3, R Webster Crowley4, Kenneth C Liu2.   

Abstract

BACKGROUND: Although chronic hydrocephalus requiring shunt placement is a known sequela of aneurysmal subarachnoid hemorrhage (aSAH), its effect on long-term functional outcomes is incompletely understood.
OBJECTIVE: To identify predictors of shunt-dependent hydrocephalus and shunt complications after aSAH and determine the effect of shunt dependence on functional outcomes in aSAH patients.
METHODS: We evaluated a database of patients treated for aSAH at a single center from 2000 to 2015. Favorable and unfavorable outcomes were defined as modified Rankin Scale grades 0 to 2 and 3 to 6, respectively. We performed statistical analyses to identify variables associated with shunt-dependent hydrocephalus, unfavorable outcome, and shunt complication.
RESULTS: Of the 888 aSAH patients, 116 had shunt-dependent hydrocephalus (13%). Older age (P = .001), intraventricular hemorrhage (IVH) (P = .004), higher World Federation of Neurological Surgeons (WFNS) grade (P < .001), surgical aneurysm treatment (P = .002), and angiographic vasospasm (P = .005) were independent predictors of shunt-dependent hydrocephalus in multivariable analysis. Functional outcome was evaluable in 527 aSAH patients (mean follow-up 18.6 mo), with an unfavorable outcome rate of 17%. Shunt placement (P < .001), shunt infection (P = .041), older age (P < .001), and higher WFNS grade (P = .043) were independently associated with an unfavorable outcome in multivariable analysis. Of the shunt-dependent patients, 18% had a shunt-related complication. Higher WFNS grade (P = .011), posterior circulation aneurysm (P = .018), and angiographic vasospasm (P = .008) were independent predictors of shunt complications in multivariable analysis.
CONCLUSION: aSAH patients with shunt-dependent hydrocephalus have significantly poorer long-term functional outcomes. Patients with risk factors for post-aSAH shunt dependence may benefit from increased surveillance, although the effect of such measures is not defined in this study.

Entities:  

Mesh:

Year:  2018        PMID: 28973194     DOI: 10.1093/neuros/nyx393

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

1.  Efficacy of translamina terminalis ventriculostomy tube in prevention of chronic hydrocephalus after aneurysmal subarachnoid hemorrhage.

Authors:  Ahmed Abdelaziz Elsharkawy; Essam Ahmed Abdelhameed
Journal:  Surg Neurol Int       Date:  2020-09-12

2.  Delayed transient obstructive hydrocephalus after cerebral aneurysm rupture: A case report.

Authors:  Yuanhong Ge; Qingjia Lai; Wenyu Wang; Xuejun Xu
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

3.  Development of machine learning models to prognosticate chronic shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage.

Authors:  Giovanni Muscas; Tommaso Matteuzzi; Eleonora Becattini; Simone Orlandini; Francesca Battista; Antonio Laiso; Sergio Nappini; Nicola Limbucci; Leonardo Renieri; Biagio R Carangelo; Salvatore Mangiafico; Alessandro Della Puppa
Journal:  Acta Neurochir (Wien)       Date:  2020-07-08       Impact factor: 2.216

4.  First-in-human endovascular treatment of hydrocephalus with a miniature biomimetic transdural shunt.

Authors:  Pedro Lylyk; Ivan Lylyk; Carlos Bleise; Esteban Scrivano; Pedro Nicolas Lylyk; Brandon Beneduce; Carl B Heilman; Adel M Malek
Journal:  J Neurointerv Surg       Date:  2021-12-03       Impact factor: 8.572

Review 5.  The Pathogenesis of Hydrocephalus Following Aneurysmal Subarachnoid Hemorrhage.

Authors:  Lu-Ting Kuo; Abel Po-Hao Huang
Journal:  Int J Mol Sci       Date:  2021-05-10       Impact factor: 5.923

6.  Shunt performance in 349 patients with hydrocephalus after aneurysmal subarachnoid hemorrhage.

Authors:  Joona Tervonen; Hadie Adams; Antti Lindgren; Antti-Pekka Elomaa; Olli-Pekka Kämäräinen; Virve Kärkkäinen; Mikael von Und Zu Fraunberg; Jukka Huttunen; Timo Koivisto; Juha E Jääskeläinen; Ville Leinonen; Terhi J Huuskonen
Journal:  Acta Neurochir (Wien)       Date:  2021-06-24       Impact factor: 2.216

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.